Cesca Therapeutics CEO Chris Xu's 2019 pay falls 28% to $472.0K

Cesca Therapeutics reports 2019 executive compensation

By ExecPay News

Published: April 21, 2020

Cesca Therapeutics reported fiscal year 2019 executive compensation information on April 21, 2020.
In 2019, three executives at Cesca Therapeutics received on average a compensation package of $264.3K, a 20% decrease compared to previous year.
Average pay of disclosed executives at Cesca Therapeutics
Chris Xu, Chief Executive Officer, received $472K in total, which decreased by 28% compared to 2018. 100.00% of Xu's compensation, or $472K, was in salary.
Jeff Cauble, Chief Financial Officer, received a compensation package of $222K, which increased by 6% compared to previous year. 80.63% of the compensation package, or $179K, was in salary.
James Xu, General Counsel, earned $99K in 2019, a 24% decrease compared to previous year.

Related executives

Chris Xu

Cesca Therapeutics

Chief Executive Officer

Jeff Cauble

Cesca Therapeutics

Chief Financial Officer

James Xu

Cesca Therapeutics

General Counsel

You may also like

Source: SEC filing on April 21, 2020.